Full-Spectrum Detection of Kinase Signaling: The Versatility of p90RSK Rabbit Polyclonal Antibodies

Concept

p90 ribosomal S6 kinase (p90RSK), a conserved serine/threonine kinase of the AGC family, acts as a key downstream effector of the Ras-MAPK signaling pathway—one of the most evolutionarily conserved regulatory networks governing cellular proliferation, survival, metabolic homeostasis, and differentiation. Endowed with two functionally independent kinase domains, p90RSK exerts its biological functions by phosphorylating a diverse array of cytoplasmic and nuclear substrates. p90RSK rabbit polyclonal antibodies are polyclonal immunological reagents generated by immunizing rabbits with p90RSK antigens, comprising a heterogeneous mixture of antibody clones that recognize multiple linear and conformational epitopes of the p90RSK protein (including all major subtypes RSK1-4). This multi-epitope recognition capability grants the antibodies a broad detection spectrum, high signal intensity, and resistance to epitope masking—making them an indispensable classic tool for the comprehensive analysis of p90RSK kinase signaling in complex biological systems.

Research Frontier

The Ras-MAPK signaling pathway and its downstream effectors such as p90RSK remain a pivotal research hotspot in molecular cell biology, oncology, and developmental biology, with p90RSK detection technologies evolving toward comprehensive, high-sensitivity, and multi-scenario applicability. Current research frontiers surrounding p90RSK rabbit polyclonal antibodies focus on three core directions: optimization of antibody preparation strategies for enhanced specificity and batch consistency, expansion of multi-platform application validation, and adaptation for high-resolution and multiplexed signaling analysis.

Cutting-edge antibody development is refining immunogen design (e.g., full-length recombinant protein vs. phosphorylated peptide immunogens) and affinity purification processes to balance the broad recognition spectrum of polyclonal antibodies with minimal non-specific cross-reactivity. Concurrently, these antibodies are being validated for use in advanced experimental techniques such as multiplex immunohistochemistry and co-immunoprecipitation coupled with high-resolution mass spectrometry, enabling the analysis of p90RSK signaling dynamics in the context of complex protein interaction networks and heterogeneous tissue microenvironments. Additionally, the development of phospho-specific p90RSK rabbit polyclonal antibodies is advancing, enabling the simultaneous detection of total p90RSK and its activated phosphorylation states (Thr359/Ser380) for a more complete understanding of kinase signaling regulation.

Research Significance

p90RSK rabbit polyclonal antibodies hold profound scientific and translational significance, serving as a cornerstone tool for unraveling the complexity of Ras-MAPK signaling and its pathological dysregulation, and supporting research in tumor biology, developmental biology, and drug development.

In basic molecular signaling research, these antibodies enable the full-spectrum detection of p90RSK—including all its splice variants, post-translationally modified forms, and family subtypes (RSK1-4)—overcoming the limitations of monoclonal antibodies that recognize only a single epitope. This comprehensive detection capability is critical for elucidating p90RSK’s functional roles in the Ras-MAPK pathway, including its activation mechanisms, substrate specificity, and protein-protein interaction networks, as well as its crosstalk with other cellular signaling pathways.

In tumor biology and translational research, aberrant activation of the Ras-MAPK/p90RSK signaling axis is a hallmark of numerous human cancers, including melanoma, lung cancer, and colorectal cancer, driving uncontrolled cell proliferation, survival, and metastasis. p90RSK rabbit polyclonal antibodies enable the detection of p90RSK expression and activation states in tumor cell lines and clinical tissue samples, facilitating the identification of correlations between p90RSK signaling and clinicopathological parameters (e.g., tumor stage, patient prognosis) and validating p90RSK as a potential anti-cancer drug target.

In experimental technique development, the multi-epitope recognition and high-sensitivity properties of p90RSK rabbit polyclonal antibodies make them an ideal tool for optimizing and validating core molecular biology techniques such as Western Blot, immunoprecipitation, and immunohistochemistry—especially for low-abundance p90RSK detection in rare cell populations or clinical samples with limited material. They also serve as a benchmark for developing novel detection assays for kinase signaling, laying the foundation for high-throughput screening and biomarker discovery.

Related Mechanism and Product Application

Why p90RSK Rabbit Polyclonal Antibodies Are a Classic Tool for Signaling Research

The enduring value of p90RSK rabbit polyclonal antibodies in kinase signaling research stems from their intrinsic polyclonal characteristics, which stand in stark contrast to monoclonal antibodies and address the unique challenges of detecting a dynamic, multi-form kinase like p90RSK:

1. Multi-epitope recognition: Derived from multiple B-cell clones, the antibodies recognize a diverse set of linear and conformational epitopes across the p90RSK protein (N-terminal kinase domain, C-terminal kinase domain, linker region). This avoids false negative results caused by epitope masking due to phosphorylation, splice variation, or protein-protein interactions— a common issue with single-epitope monoclonal antibodies.
2. High signal intensity: The simultaneous binding of multiple antibody clones to a single p90RSK molecule amplifies the detection signal, enabling high-sensitivity detection of low-abundance p90RSK in cell and tissue samples, and supporting semi-quantitative analysis of kinase expression levels.
3. Broad recognition spectrum: The antibodies detect all major p90RSK subtypes (RSK1-4) and their various modified forms, providing a comprehensive view of p90RSK family signaling—critical for understanding the functional redundancy and specificity of individual RSK subtypes in biological processes.
4. Robustness in complex samples: Their ability to recognize multiple epitopes makes the antibodies highly resistant to the structural changes of p90RSK in complex biological samples (e.g., formalin-fixed paraffin-embedded tumor tissues), ensuring reliable detection across diverse experimental conditions.

Preparation Strategies That Determine p90RSK Rabbit Polyclonal Antibody Performance

The quality, specificity, and performance of p90RSK rabbit polyclonal antibodies are dictated by systematic immunogen design and rigorous post-immunization purification, with two core strategies tailored to distinct research applications:

1. Immunogen design:
• Full-length recombinant p90RSK immunogen: Generates a diverse antibody population that recognizes all structural domains of p90RSK, ideal for total p90RSK detection and immunoprecipitation applications where the capture of all p90RSK forms is required.
• Phosphorylated peptide immunogen: Targets key activation phosphorylation sites of p90RSK (Thr359, Ser380), enriching phospho-specific antibody clones for the detection of p90RSK’s activated signaling state—a key readout of Ras-MAPK pathway activity.
2. Immunization and purification optimization:
• Extended immunization periods and high-quality adjuvants promote the maturation of high-affinity B-cell clones, enhancing the antibody’s binding affinity and sensitivity.
• Antigen-affinity column purification removes cross-reactive antibodies targeting unrelated proteins, improving the antibody’s specificity while preserving its broad p90RSK recognition spectrum.
• Pooling serum from multiple immunized rabbits minimizes individual animal variability, ensuring excellent batch-to-batch consistency—a critical feature for long-term research and multi-center experiments.

Advantages in Western Blot Detection

p90RSK rabbit polyclonal antibodies exhibit unique and irreplaceable advantages in Western Blot, the gold standard technique for kinase expression and activation analysis:

• Detection of all p90RSK variants: p90RSK (≈90 kDa) exhibits slight electrophoretic mobility shifts across cell types and stimulation conditions due to differential phosphorylation and splice variation. The multi-epitope recognition capability of the antibodies ensures effective detection of all these variant forms, eliminating false negatives from epitope masking.
• High sensitivity for low-abundance samples: The signal amplification effect of multi-clone binding enables the clear detection of low-expression p90RSK in primary cells, rare cell populations, or clinical tissue samples—where monoclonal antibodies may fail to generate a detectable signal.
• Flexibility for pan-RSK or subtype-specific detection: The antibodies naturally recognize all p90RSK subtypes (RSK1-4) via conserved domain recognition, making them ideal for pan-RSK signaling analysis. For subtype-specific detection, pre-adsorption experiments can be performed to eliminate cross-reactivity, balancing broad detection and subtype specificity.

Functional Roles in Immunoprecipitation

Immunoprecipitation (IP) is a core technique for studying protein-protein interactions and post-translational modifications, and p90RSK rabbit polyclonal antibodies are optimized for high performance in this application:

• Superior target capture efficiency: The recognition of multiple p90RSK epitopes ensures successful capture of the kinase even if some domains are masked by binding partners (e.g., upstream kinases ERK, downstream substrates). This stands in contrast to monoclonal antibodies, which may fail to capture p90RSK if their single epitope is occupied.
• Enrichment of p90RSK protein complexes: In IP coupled with mass spectrometry (IP-MS), the antibodies efficiently enrich endogenous p90RSK and its associated protein complexes from cell lysates, enabling the identification of novel p90RSK-interacting proteins and the mapping of its protein interaction network.
• Analysis of p90RSK activation dynamics: Combined with phospho-specific antibodies in Western Blot, IP with p90RSK rabbit polyclonal antibodies enables the detection of p90RSK phosphorylation changes under specific cellular stimuli (e.g., growth factor treatment), elucidating the dynamic regulation of p90RSK activation in the Ras-MAPK pathway.

Unique Value in Immunohistochemistry (IHC)

For the detection of p90RSK in formalin-fixed paraffin-embedded (FFPE) tissue samples— the gold standard for clinical and translational research—p90RSK rabbit polyclonal antibodies offer unparalleled value:

• Resistance to fixation-induced epitope damage: Formalin fixation causes protein cross-linking and epitope masking, but the multi-epitope recognition capability of the antibodies ensures that at least some epitopes remain accessible, resulting in higher staining success rates and stronger specific signals in IHC.
• Clinical translational applicability: In tumor tissue microarray studies, the antibodies enable the quantitative analysis of p90RSK expression levels and their correlation with clinicopathological parameters (e.g., tumor grade, lymph node metastasis), supporting the validation of p90RSK as a clinical biomarker.
• Compatibility with multiplex IHC: As rabbit-derived antibodies, they can be combined with mouse-derived monoclonal antibodies for other cellular markers (e.g., proliferation marker Ki-67, immune cell marker CD8) in multiplex IHC. Species-specific secondary antibodies enable multi-labeling, allowing the analysis of p90RSK signaling activation in distinct cell subpopulations within the tumor microenvironment.
• Optimizable for phospho-specific detection: With strict control of antigen retrieval conditions (e.g., avoiding alkaline conditions that cause dephosphorylation), phospho-specific p90RSK rabbit polyclonal antibodies can detect the activated form of p90RSK in FFPE tissues, linking kinase signaling activation to pathological phenotypes.

p90RSK Antibodies in ANT BIO PTE. LTD.’s Research Ecosystem

As a leading provider of life science research reagents, ANT BIO PTE. LTD. leverages its Starter sub-brand—specialized in the development of high-performance antibodies—to engineer the p90RSK Rabbit Polyclonal Antibody (S0B0649), a flagship reagent optimized for the full-spectrum detection of p90RSK kinase signaling. Developed via a mature rabbit polyclonal antibody platform (encompassing rational immunogen design, optimized immunization strategies, affinity purification, and multi-platform validation), this antibody embodies the core advantages of p90RSK rabbit polyclonal antibodies and meets the rigorous demands of basic and translational signaling research:

• Broad p90RSK family recognition: Immunized with high-purity recombinant p90RSK protein, the antibody recognizes multiple linear and conformational epitopes across all major p90RSK subtypes (RSK1-4) and exhibits excellent cross-species reactivity (human, mouse, rat), enabling comprehensive and stable detection of total p90RSK in diverse experimental systems.
• Exceptional sensitivity: The multi-epitope recognition-driven signal amplification enables high-sensitivity detection of low-abundance p90RSK in Western Blot, making it ideal for low-expression cell lines, primary cells, and limited clinical tissue samples.
• Multi-platform compatibility: Rigorously validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunofluorescence (IF), Immunohistochemistry (IHC), and ELISA, the antibody adapts to all key experimental techniques for p90RSK detection and functional analysis, eliminating the need for multiple antibody reagents for different applications.
• Superior stability and batch consistency: Rigorous quality control and batch validation processes ensure highly consistent performance across production batches, with stable physicochemical properties—providing reliable core reagents for long-term research projects, multi-center experiments, and drug development studies.

ANT BIO PTE. LTD. further supports researchers with comprehensive technical resources for the p90RSK Rabbit Polyclonal Antibody (S0B0649), including subtype and species cross-reactivity validation data, optimized application protocols for all experimental platforms, and typical experimental results (e.g., FFPE tumor tissue IHC staining, IP-MS protein interaction data). Our professional technical team provides expert guidance for experimental design, Ras-MAPK/p90RSK signaling pathway analysis, tumor biomarker research, and kinase function studies—empowering researchers to accelerate breakthroughs in kinase signaling research and translational oncology.

Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.

Disclaimer

This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.